Thalidomide abolishes transfusion-dependence in selected patients with myelodysplastic syndromes

Haematologica. 2002 Aug;87(8):884-6.
No abstract available

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anemia, Refractory, with Excess of Blasts / blood
  • Anemia, Refractory, with Excess of Blasts / drug therapy*
  • Anemia, Refractory, with Excess of Blasts / therapy
  • Blood Transfusion*
  • Combined Modality Therapy
  • Drug Evaluation
  • Erythropoietin / blood
  • Female
  • Fetal Hemoglobin / analysis
  • Humans
  • Male
  • Middle Aged
  • Thalidomide / adverse effects
  • Thalidomide / therapeutic use*
  • Treatment Outcome

Substances

  • Erythropoietin
  • Thalidomide
  • Fetal Hemoglobin